Rite Aid Stock News

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Labor Shortage Hits CVS, Walgreens, Forcing Pharmacies To Close Early Labor shortages at the biggest U.S. drugstore store chains force their in-house pharmacies to close on weekends as the COVID-19 omicron variant continues to spread. Pharmacists and technicians are calling out sick, leaving CVS Health Corp. and Walgreens Boots Alliance Inc. with no other choice but to reduce hours of operations. WSJ reports CVS and Walgreens closing pharmacies on weekends is "unusual," but it reflects today''s environment of pharmacist and technician shortages due to sickness as omicron rapidly spreads. Both drugstores could not quantify weekend closures because the number each week fluctuates. Customers are already reporting pharmacies have unexpectedly closed in Washington, D.C., New Gloucester, Maine, and New Paltz, New York. There have been instances when people have shown up for scheduled COVID tests to only find out the pharmacy was closed. Zach Fox of Akron, Ohio, told WSJ his wife had been without pain medication because their local CVS'' pharmacy was closed. "At this point, I''m getting angry.

CVS Health <> has led its peers Walgreens Boots Alliance <> and Rite Aid <> to record a new 52-week high after the company raised its 2021 earnings guidance ahead

Although high costs and a drab view remain concerning, Rite Aid (RAD) looks well-positioned on robust demand, enhanced omni-channel capabilities and strength in PBM.

Although high costs and a drab view remain concerning, Rite Aid (RAD) looks well-positioned on robust demand, enhanced omni-channel capabilities and strength in PBM.

Rite Aid Corp. (RAD) shares closed today 12.4% lower than it did at the end of yesterday. The stock is currently up 0.1% year-to-date, down 7.0% over the past 12 months, and down 91.0% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $15.62 and as low as $14.39 this week.Shares closed 60.3% below its 52-week high and 12.0% above its 52-week low.Trading volume this week was 26.2% higher than the 10-day average and 8.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Consumer Discretionary industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -91.5% The company's stock price performance over the past 12 months beats the peer average by -38.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Investors are optimistic about Bio-Rad (BIO) owing to robust segmental performances and a rebound in non-COVID businesses.

Rite Aid Co. (NYSE:RAD) shares traded down 7.4% on Wednesday . The stock traded as low as $13.77 and last traded at $13.93. 48,118 shares traded hands during mid-day trading, a decline of 98% from the average session volume of 2,237,305 shares. The stock had previously closed at $15.05. Several equities research analysts have recently []

Related Stocks: RAD ,

Rite Aid Co. (NYSE:RAD) CEO Heyward R. Donigan acquired 14,350 shares of the stock in a transaction that occurred on Wednesday, December 22nd. The stock was purchased at an average price of $13.93 per share, for a total transaction of $199,895.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which []

Rite Aid may form closer ties with the pharmacy benefit manager Prime Therapeutics, which is owned by Blue Cross and Blue Shield plans.

Rite Aid Co. (NYSE:RAD) saw strong trading volume on Tuesday following a stronger than expected earnings report. 59,911 shares were traded during mid-day trading, a decline of 96% from the previous session’s volume of 1,684,412 shares.The stock last traded at $14.33 and had previously closed at $12.40. The company reported $0.15 EPS for the quarter, […] The post Rite Aid (NYSE:RAD) Sees Strong Trading Volume on Better-Than-Expected Earnings appeared first on ETF Daily News .

Rite Aid may form closer ties with the pharmacy benefit manager Prime Therapeutics, which is owned by Blue Cross and Blue Shield plans.

Increased demand for COVID-19 vaccination and testing, and growth in the Retail Pharmacy unit aid Rite Aid's (RAD) Q3 results.

US drugstore chain Rite Aid has reported 1.8% increase in revenues from continuing operations for the third quarter of fiscal Read More... The post Rite Aid reports revenue increase of 1.8% in 2022 third quarter appeared first on Verdict Retail .